Longitudinal Monitoring of Inflammation in Cirrhosis
Completed · Not applicable
Conditions studied: Cirrhosis, Liver
In brief
Longitudinal monitoring of inflammation using skin devices may help predict outcomes compared to traditional blood draws
Key facts
- Study ID
- NCT05538962
- Run by
- Hunter Holmes Mcguire Veteran Affairs Medical Center
- People needed
- 85
- Starts
- 2022-09-01
- Expected to finish
- 2024-07-31
- Last updated by the study team
- 2024-08-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age >18 years
- Able to give consent
You may not qualify if…
- Unable/unwilling to consent
- Chronic diseases
- Unable to come in daily or be available daily for 3 days.
- Outpatients with Cirrhosis:
- Inclusion criteria:
- Age >18 years
- Able to give consent
- Cirrhosis defined by any one of the following
- Cirrhosis on liver biopsy or transient wave elastography
- Nodular liver on imaging
- Endoscopic or radiological evidence of varices in a patient with chronic liver disease
- Platelet count <150,000/mm3 and AST/ALT ratio >1 in a patient with chronic liver disease
- Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
- Exclusion criteria:
- Unable/unwilling to consent
- Unclear diagnosis of cirrhosis
- Unable to come in daily or be available daily for 3 days.
- Inflammatory bowel disease or other diseases that require immunosuppressive therapy use
- Inpatients with Cirrhosis:
- Inclusion criteria:
- Age >18 years
- Able to give consent
- Cirrhosis defined by any one of the following
- Cirrhosis on liver biopsy or transient wave elastography
- Nodular liver on imaging
Where it is running
- Hunter Holmes McGuire VA Medical Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.